{"id":9726,"date":"2021-04-28T11:20:25","date_gmt":"2021-04-28T09:20:25","guid":{"rendered":"https:\/\/ggba.swiss\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/"},"modified":"2023-07-04T13:43:36","modified_gmt":"2023-07-04T11:43:36","slug":"onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/","title":{"rendered":"ONWARD, spin-off de l’EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re"},"content":{"rendered":"

Avec pour mission de restaurer la mobilit\u00e9, l’ind\u00e9pendance et la sant\u00e9 des personnes souffrant de l\u00e9sions de la moelle \u00e9pini\u00e8re, la spin-off de l’EPFL, ONWARD<\/a>, a d\u00e9velopp\u00e9 la th\u00e9rapie ARC.<\/p>\n

La th\u00e9rapie ARC peut \u00eatre administr\u00e9e par un syst\u00e8me implantable appel\u00e9 ARC-IM et un syst\u00e8me externe appel\u00e9 ARC-EX. Les deux plateformes sont con\u00e7ues pour fournir une stimulation cibl\u00e9e et programm\u00e9e de la moelle \u00e9pini\u00e8re afin de restaurer le mouvement, l’ind\u00e9pendance et la sant\u00e9 des personnes atteintes de l\u00e9sions de la moelle \u00e9pini\u00e8re.<\/p>\n

ARC-IM et ARC-EX ont chacun re\u00e7u la d\u00e9signation de \u00ab\u00a0dispositif r\u00e9volutionnaire\u00a0\u00bb (Breakthrough Device Designation) de la part du FDA. ARC-EX fait actuellement l’objet d’essais cliniques aux \u00c9tats-Unis, au Canada, au Royaume-Uni et en Europe occidentale dans le cadre d’une \u00e9tude pivot appel\u00e9e Up-LIFT<\/a>.<\/p>\n

Pour acc\u00e9l\u00e9rer le d\u00e9veloppement et la commercialisation de ses deux plateformes, ONWARD a lev\u00e9 $ 32 millions lors d’un tour de table men\u00e9 par Invest-NL<\/a>, un investisseur n\u00e9erlandais, et Olympic Investments<\/a>, la branche d’investissements priv\u00e9s de la Fondation Onassis.<\/p>\n

Plusieurs nouveaux investisseurs, dont Verve Ventures<\/a>, et tous les investisseurs existants d’ONWARD, ont \u00e9galement particip\u00e9 au financement, notamment LSP<\/a>, INKEF Capital<\/a>, Gimv<\/a> et Wellington Partners<\/a>, des investisseurs de premier plan dans le domaine des technologies m\u00e9dicales.<\/p>\n

Fond\u00e9e en 2014 avec un si\u00e8ge social aux Pays-Bas et \u00e0 l’EPFL Innovation Park<\/a> \u00e0 Lausanne (canton de Vaud), ONWARD Medical (anciennement connue sous le nom de GTX Medical) a \u00e9galement une pr\u00e9sence am\u00e9ricaine croissante \u00e0 Boston.<\/p>\n","protected":false},"excerpt":{"rendered":"

ONWARD a lev\u00e9 $ 32 millions pour poursuivre le d\u00e9veloppement et la commercialisation de sa th\u00e9rapie ARC qui stimule la moelle \u00e9pini\u00e8re pour r\u00e9tablir la motricit\u00e9.<\/p>\n","protected":false},"author":3,"featured_media":9727,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1041,1060],"class_list":["post-9726","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr","tag-medtech-fr"],"acf":[],"yoast_head":"\nONWARD, spin-off de l'EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ONWARD, spin-off de l'EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"ONWARD a lev\u00e9 $ 32 millions pour poursuivre le d\u00e9veloppement et la commercialisation de sa th\u00e9rapie ARC qui stimule la moelle \u00e9pini\u00e8re pour r\u00e9tablir la motricit\u00e9.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-28T09:20:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:43:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/ONWARD-Arc-630x380-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"ONWARD, spin-off de l’EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re\",\"datePublished\":\"2021-04-28T09:20:25+00:00\",\"dateModified\":\"2023-07-04T11:43:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/\"},\"wordCount\":287,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ONWARD-Arc-630x380-3.png\",\"keywords\":[\"Financing\",\"Medtech\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/\",\"name\":\"ONWARD, spin-off de l'EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ONWARD-Arc-630x380-3.png\",\"datePublished\":\"2021-04-28T09:20:25+00:00\",\"dateModified\":\"2023-07-04T11:43:36+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ONWARD-Arc-630x380-3.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ONWARD-Arc-630x380-3.png\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONWARD, spin-off de l’EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ONWARD, spin-off de l'EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/","og_locale":"fr_FR","og_type":"article","og_title":"ONWARD, spin-off de l'EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re - Greater Geneva Bern area","og_description":"ONWARD a lev\u00e9 $ 32 millions pour poursuivre le d\u00e9veloppement et la commercialisation de sa th\u00e9rapie ARC qui stimule la moelle \u00e9pini\u00e8re pour r\u00e9tablir la motricit\u00e9.","og_url":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2021-04-28T09:20:25+00:00","article_modified_time":"2023-07-04T11:43:36+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/ONWARD-Arc-630x380-3.png","type":"image\/png"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"ONWARD, spin-off de l’EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re","datePublished":"2021-04-28T09:20:25+00:00","dateModified":"2023-07-04T11:43:36+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/"},"wordCount":287,"image":{"@id":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ONWARD-Arc-630x380-3.png","keywords":["Financing","Medtech"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/","url":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/","name":"ONWARD, spin-off de l'EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ONWARD-Arc-630x380-3.png","datePublished":"2021-04-28T09:20:25+00:00","dateModified":"2023-07-04T11:43:36+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ONWARD-Arc-630x380-3.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ONWARD-Arc-630x380-3.png","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/onward-spin-off-de-lepfl-leve-32-millions-therapies-de-moelle-epiniere\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"ONWARD, spin-off de l’EPFL, l\u00e8ve $ 32 millions pour ses th\u00e9rapies de moelle \u00e9pini\u00e8re"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=9726"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9726\/revisions"}],"predecessor-version":[{"id":17920,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9726\/revisions\/17920"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/9727"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=9726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=9726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=9726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}